During the 5th “Health of Poles” Congress, held on November 13-14 this year in Kajetany, three projects involving Acellmed were presented:

– Oncology – “Personalized, liposomal therapy for acute myeloid leukemia (AML) based on small inhibitory RNAs” (RPO 1.2 WSL)

– Antiviral – “Antiviral platform for SARS group viruses (including SARS-CoV-2), MERS, and INFLUENZA, targeting virus binding to the ACE2 receptor” (ABM grant)

– Ophthalmic – “Biodegradable dressing for corneal reconstruction with limbal stem cells, prepared within the framework of autologous transplantation, using bio-printing and 3D printing” (RPO 1.2 WSL)

We lead these projects as a consortium along with our excellent scientific and clinical partners: Silesian Park of Medical Technology Kardio-Med Silesia, University of Wrocław, University of Environmental and Life Sciences in Wrocław, and the Medical University of Silesia in Katowice.

We believe that in the not-so-distant future, our solutions will enter clinical practice and serve patients well, improving their health and quality of life.

Huge thanks and applause to the Congress Organizers under the leadership of Professor Henryk Skarżyński.